Atrion Corp (ATRI)
398.08
-26.11
(-6.16%)
USD |
NASDAQ |
Apr 25, 16:00
398.08
0.00 (0.00%)
After-Hours: 20:00
Atrion SG&A Expense (Quarterly): 8.068M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.068M |
September 30, 2023 | 7.801M |
June 30, 2023 | 8.268M |
March 31, 2023 | 8.981M |
December 31, 2022 | 8.049M |
September 30, 2022 | 6.799M |
June 30, 2022 | 8.251M |
March 31, 2022 | 7.617M |
December 31, 2021 | 8.013M |
September 30, 2021 | 6.919M |
June 30, 2021 | 6.627M |
March 31, 2021 | 6.098M |
December 31, 2020 | 6.124M |
September 30, 2020 | 5.927M |
June 30, 2020 | 6.331M |
March 31, 2020 | 6.47M |
December 31, 2019 | 6.067M |
September 30, 2019 | 6.082M |
June 30, 2019 | 6.402M |
March 31, 2019 | 6.571M |
December 31, 2018 | 5.919M |
September 30, 2018 | 6.038M |
June 30, 2018 | 6.354M |
March 31, 2018 | 6.247M |
December 31, 2017 | 5.988M |
Date | Value |
---|---|
September 30, 2017 | 5.777M |
June 30, 2017 | 6.151M |
March 31, 2017 | 5.765M |
December 31, 2016 | 5.617M |
September 30, 2016 | 5.084M |
June 30, 2016 | 5.544M |
March 31, 2016 | 5.684M |
December 31, 2015 | 5.404M |
September 30, 2015 | 5.248M |
June 30, 2015 | 5.995M |
March 31, 2015 | 5.478M |
December 31, 2014 | 5.308M |
September 30, 2014 | 5.591M |
June 30, 2014 | 6.002M |
March 31, 2014 | 5.513M |
December 31, 2013 | 5.282M |
September 30, 2013 | 5.181M |
June 30, 2013 | 5.187M |
March 31, 2013 | 5.179M |
December 31, 2012 | 4.507M |
September 30, 2012 | 4.465M |
June 30, 2012 | 4.862M |
March 31, 2012 | 5.179M |
December 31, 2011 | 4.288M |
September 30, 2011 | 4.514M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
5.927M
Minimum
Sep 2020
8.981M
Maximum
Mar 2023
7.100M
Average
6.799M
Median
Sep 2022
SG&A Expense (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.694M |
Retractable Technologies Inc | 4.158M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |
Catheter Precision Inc | 2.729M |